Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin, 300211, China.
Department of Reproductive Health, W.F. Maternal and Child Health Hospital, Weifang, 261000, Shandong Province, China.
World J Surg Oncol. 2021 Aug 28;19(1):255. doi: 10.1186/s12957-021-02375-3.
To evaluate the clinicopathologic value of morphological growth patterns of small renal cell carcinoma (sRCC) and determine the actual demand for taking a rim of healthy parenchyma to avoid positive SM.
Data was collected from 560 sRCC patients who underwent laparoscopic surgeries from May 2010 to October 2017. One hundred forty-nine cases received nephron-sparing surgery (NSS) and others received radical nephrectomy (RN). All specimens were analyzed separately by two uropathologists, and three morphological growth patterns were identified. The presence of pseudocapsule (PC), surgical margins (SM), and other routine variables were recorded. The relationship between growth patterns and included variables was measured by the χ test and Fisher's exact probability test. Survival outcomes were evaluated by Kaplan-Meier method and the log-rank test.
The median age of patients was 63.2 years old and the mean tumor diameter was 3.0 cm. Four hundred eighty (85.7%) cases were clear cell RCC and 541 (96.6%) cases were at the pT1a stage. Peritumoral PC was detected in 512 (92.5%) specimens, and the ratio of tumor invasion in PC in infiltration pattern increased obviously than that of the other growth patterns. Similarly, the pT stage was significantly correlated with the infiltration pattern as well. One hundred forty-nine patients underwent NSS and 3 (2.0%) of them showed positive SM after operation. Statistical differences of the 5-year overall survival (OS) and the cancer-specific survival (CSS) existed between different morphological growth patterns, PC status, and pT stages.
Morphological growth patterns of sRCC might be used as a potential biomarker to help operate NSS to avoid the risk of positive SM. How to distinguish different morphological growth patterns before operation and the effectiveness of the growth pattern as a novel proposed parameter to direct NSS in sRCC patients deserves further exploration.
评估小肾细胞癌(sRCC)形态生长模式的临床病理价值,并确定为避免阳性切缘(SM)而实际需要切除健康肾实质边缘的范围。
收集 2010 年 5 月至 2017 年 10 月期间 560 例接受腹腔镜手术的 sRCC 患者的数据。149 例患者接受了保留肾单位手术(NSS),其余患者接受了根治性肾切除术(RN)。两名泌尿科病理学家分别对所有标本进行分析,并确定了三种形态生长模式。记录了假包膜(PC)、手术切缘(SM)和其他常规变量的存在情况。通过 χ 检验和 Fisher 确切概率检验测量生长模式与纳入变量之间的关系。通过 Kaplan-Meier 方法和对数秩检验评估生存结果。
患者的中位年龄为 63.2 岁,肿瘤平均直径为 3.0cm。480 例(85.7%)为透明细胞肾细胞癌,541 例(96.6%)为 pT1a 期。512 例(92.5%)标本检测到肿瘤周围 PC,浸润模式下肿瘤侵犯 PC 的比例明显高于其他生长模式。同样,pT 期与浸润模式也有显著相关性。149 例患者接受 NSS,其中 3 例(2.0%)术后 SM 阳性。不同形态生长模式、PC 状态和 pT 期之间的 5 年总生存率(OS)和癌症特异性生存率(CSS)存在统计学差异。
sRCC 的形态生长模式可能作为潜在的生物标志物,帮助行 NSS 手术以避免阳性 SM 的风险。如何在术前区分不同的形态生长模式,以及生长模式作为指导 sRCC 患者行 NSS 的新提出的参数的有效性,值得进一步探索。